Phosphorothioate Oligonucleotides for RT Hot Start PCR
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current PCR 'hot start' technologies are inadequate for reverse transcriptase, leading to non-specific amplification and false signals due to enzyme activity at room temperature, which interferes with DNA diagnostics and forensics.
Innovation Solution
The use of sulfur-containing oligonucleotides, specifically phosphorothioate-linked oligonucleotides (S-oligos), that inhibit enzyme activity at lower temperatures but release at elevated temperatures, preventing non-specific interactions and maintaining enzymatic specificity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional hot start methods (temperature controlled magnesium concentration, temperature activated dNTPs and primers, chemically modified or antibody inhibited polymerases) are used, then polymerase non-specific activity is reduced, but these methods are ineffective for reverse transcriptase and require temperatures that would denature RT
Solution Approach 1:
The patent introduces a small molecule inhibitor as an intermediary substance that mediates between the need to suppress RT activity at room temperature and the need to maintain RT functionality for subsequent amplification. The inhibitor acts as a temporary blocking agent that is removed by heat activation, allowing RT to function only when needed.
Solution Approach 2:
The patent employs parameter changes by using a temperature-sensitive small molecule inhibitor that changes its binding affinity to RT based on temperature. At room temperature, the inhibitor binds tightly to suppress non-specific activity; at elevated temperatures (e.g., 95°C), the inhibitor denatures or releases, allowing RT to become active for specific amplification.
2Ease of operation
If reverse transcriptase is active at room temperature during PCR setup, then primer extension can occur, but this leads to non-specific amplification, unwanted background products, and false signals
Solution Approach 1:
The patent applies preliminary anti-action by introducing a small molecule inhibitor that pre-blocks RT activity during the PCR setup phase. This preliminary inhibition prevents harmful non-specific amplification and primer-dimer formation before the specific amplification conditions are established, ensuring that primer extension only occurs when intended.
Solution Approach 2:
The patent uses preliminary action by allowing the inhibitor to bind to RT during the setup phase, then removing this inhibition through heat activation at the beginning of the amplification cycles. This preliminary control mechanism ensures that RT is activated only after all reagents are properly mixed and before specific amplification begins.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively reduces non-specific products and false signals, enhancing the accuracy of nucleic acid amplification by controlling enzyme activity, particularly for reverse transcriptase in PCR reactions.
Implementation Method 1
The use of sulfur-containing oligonucleotides, specifically phosphorothioate-linked oligonucleotides (S-oligos), that inhibit enzyme activity at lower temperatures but release at elevated temperatures
Implementation Method 2
The use of sulfur-containing oligonucleotides, specifically phosphorothioate-linked oligonucleotides (S-oligos), that inhibit enzyme activity at lower temperatures but release at elevated temperatures
Data Source
AI summary
Disclosed herein are methods of nucleic acid amplification, including methods of preventing non-specific reaction of a nucleotide sequence with a DNA modifying enzyme.